DARE Dare Bioscience: Net earnings per share for the last 12 months

Public company logo of Dare Bioscience (DARE)

Despite the patent protection of hydrogels and the success of Xaciato, Dare Bioscience, Inc. (DARE) continues to experience volatility. The annual net income per share growth rate (ttm) visualizes this gap, where the level of -83.00 represents the current value. US centers creating scarce treatment methods provide stability, while bioethical development standards and strict environmental resource disposal controls restore confidence.

Dare Bioscience (DARE): Earnings per share for the last twelve months from 02/11/2024 to 11/14/2026

Daré Bioscience, Inc. - analytical breakdowns and key metrics (DARE)

- price and consensus price forecast:
Market Price Dare Bioscience|DARE - Price Target Chart
- company stock capitalization data:
Market Valuation Dare Bioscience Inc.|DARE - Enterprise Value
- book capitalization data:
Net Asset Value per Share Daré Bioscience|DARE - Company Book Value|Capitalization to Book Value Ratio darebioscience.com|DARE - Company Total Assets
- company total debt and liquidity indicators:
Debt to Equity Ratio Dare Bioscience, Inc.|DARE - Long-Term Debt to Capital|Short-Term Debt to Capital darebioscience.com|DARE - Company Debts|Debt to Net Assets Ratio Dare Bioscience Inc.|DARE - Company Long-Term Debts|Short-Term Debt Daré Bioscience|Intermediate Coverage Ratio darebioscience.com
- net income and valuation ratios data:
DARE - Net Profit|Expected Profit Dare Bioscience, Inc.|DARE - P/E Multiple|Market Cap to Projected Earnings Daré Bioscience, Inc.|DARE - Price/Earnings to Growth Ratio|Company Value to EBITDA Daré Bioscience, Inc.|DARE - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Daré Bioscience|DARE - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months darebioscience.com|DARE - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Dare Bioscience, Inc.
- revenue and sales details:
DARE - Revenue and Sales Volume|Company Expected Sales Volume Dare Bioscience|DARE - Price-to-Revenue Ratio|Market Cap to Projected Revenue Dare Bioscience Inc.
Initial company analysis:Daré Bioscience DARE
Finished products of Dare Bioscience Inc.

To assess the fundamental stability of Dare Bioscience, Inc. (DARE), investors must analyze the year-over-year dynamics of net earnings per share. This chart of relative EPS YoY TTM changes visualizes profit growth rates over the last twelve months, allowing for the tracking of commercial deal effectiveness and the impact of Big Pharma sponsorship on the final profitability of the company's R&D model.

Competitor analysis for Dare Bioscience, Inc.

Organon (OGN) - Net earnings per share for the last 12 months|TherapeuticsMD Corp (TXMD) - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Palatin Corp (PTN)